Podcast: Noticing Neffy – A ‘Transformative Treatment’ For Type 1 Allergies

Richard Lowenthal, co-founder, and CEO of ARS Pharma, highlights the crucial unmet need for needle-free injections. Challenging issues posed by current epinephrine injectors, In Vivo questions the current and future progression of Neffy.